-
Despite widespread protests from the infection control community, the Occupational Safety and Health Administration (OSHA) has not rescinded its controversial requirement for annual respirator fit-testing for workers who may be exposed to tuberculosis patients.
-
The Centers for Disease Control and Prevention (CDC) has issued interim guidelines for use of antiviral medications during the 2004-2005 influenza season. The guidelines are summarized as follows.
-
While influenza antiviral medications comprise an important second line of defense during a troubled flu season, the Centers for Disease Control and Prevention (CDC) is reluctant to promote the drugs as a solution to the vaccine shortage.
-
Infection control professionals are rolling out their severe acute respiratory syndrome (SARS) plans and steeling themselves for overwhelmed emergency departments (ED) after the nations leading ED clinicians warned that a perfect storm may be forming this influenza season.
-
-
Toenail Chromium in Men With Diabetes and Cardiovascular Disease; Combination of Fenofibrate and Rosiglitazone and HDL Cholesterol; Outcomes for Patients with Diet-Controlled Diabetes; Erythromycin and the Risk of Sudden Death; Acute Hyperglycemia, Mood, and Cognitive Performance in Type 2 Diabetics; Psychosocial Risk Factors and Risk of Acute MI.
-
-
One of the great challenges in the whole world of quality and patient safety is learning to take advantage of the richness of clinical cases, says Robert M. Wachter, MD, professor and associate chairman in the department of medicine at the University of California, San Francisco (UCSF) and chief of the medical service at UCSF Medical Center.
-
-
Almost one-third of heart failure patients face an increased risk of death because they do not receive an angiotensin-converting enzyme (ACE) inhibitor, according to a report in the Aug. 3, 2004, rapid-access issue of Circulation: Journal
of the American Heart Association.
